Walleye Trading’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,800
Closed -$490K 5710
2020
Q4
$490K Sell
6,800
-12,800
-65% -$670K ﹤0.01% 2679
2020
Q3
$893K Sell
19,600
-38,500
-66% -$1.61M ﹤0.01% 1746
2020
Q2
$2.63M Buy
58,100
+55,500
+2,135% +$2.49M 0.02% 901
2020
Q1
$100K Buy
+2,600
New +$120K ﹤0.01% 3115
2019
Q4
Sell
-600
Closed -$24K 4885
2019
Q3
$24K Buy
+600
New +$25.9K ﹤0.01% 3737
2019
Q2
Sell
-2,600
Closed -$163K 4817
2019
Q1
$163K Sell
2,600
-26,500
-91% -$1.82M ﹤0.01% 3177
2018
Q4
$1.74M Buy
29,100
+5,200
+22% +$312K 0.01% 1185
2018
Q3
$1.54M Sell
23,900
-1,300
-5% -$72.5K 0.01% 1616
2018
Q2
$1.13M Buy
25,200
+14,700
+140% +$586K 0.01% 1963
2018
Q1
$326K Sell
10,500
-20,300
-66% -$668K ﹤0.01% 3070
2017
Q4
$922 Sell
30,800
-28,500
-48% -$825K ﹤0.01% 2009
2017
Q3
$1.96K Buy
59,300
+44,700
+306% +$1.55M 0.01% 1284
2017
Q2
$489 Buy
+14,600
New +$436K ﹤0.01% 2403

Other funds holding BEAT

Walleye Trading's BEAT Position: Q2 2020 in Review

Walleye Trading sold out of BioTelemetry, Inc. (BEAT) in Q2 2020, closing a stake of 2,155 shares — an estimated $96.6K sold.

Walleye Trading first reported a position in BEAT in Q2 2015 and held it in 9 quarters. The position peaked at $302K in Q1 2019. 215 funds tracked by Wall St. Rank hold BEAT as of Q2 2020.

  • Walleye Trading reported no remaining BioTelemetry, Inc. position as of Q2 2020 after selling out during the quarter.
  • Walleye Trading sold 2,155 BioTelemetry, Inc. shares in Q2 2020, an estimated $96.6K.
  • Walleye Trading first reported a position in BioTelemetry, Inc. in Q2 2015 and held it in 9 quarters.
  • Walleye Trading's BioTelemetry, Inc. position peaked at $302K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.